Framework-based supply contract for multiple-sclerosis medicines
Plataforma de serveis de contractació pública de Catalunya
Overview
This contract under a framework agreement covers medicines for multiple-sclerosis treatment for Consorci Sanitari del Maresme. The API identifies the contract budget without VAT, budget including VAT, estimated value, 4% VAT and a one-year term. Currency is not stated, and the available fields identify no supplier or award amount.
Information based on the public notice
Ask about this tender
What the buyer needs
Supply of medicines for multiple-sclerosis treatment under an existing framework agreement.
Tender details
- Buyer
- Consorci Sanitari del Maresme
- Country
Spain
- Procedure
- Negotiated procedure without prior publication
- Classification
- CPV 33690000 · NUTS ES51
- Notice reference
- 8791251
- Budget excluding VAT
- 1,392,022.47 (currency not stated)
- Budget including VAT
- 1,447,703.36 (currency not stated)
- Estimated contract value
- 1,667,896.38 (currency not stated)
- VAT
- 4%; term: one year
What to check in the tender documents
- The retrieved fields name no supplier or award amount.
Original notice
Read the original description
Contracte basat de l'Acord Marc del Subministrament de Medicaments per al tractament de l'Esclerosi Múltiple
Official source: Plataforma de serveis de contractació pública de Catalunya ↗
Notice updates
October 12, 2026 · Version 2
Summary and analysis updated
Contracte basat de l'Acord Marc del Subministrament de Medicaments per al tractament de l'Esclerosi Múltiple
Contracte basat de l'Acord Marc del Subministrament de Medicaments per al tractament de l'Esclerosi Múltiple
October 12, 2026 · Version 1
Published
Contracte basat de l'Acord Marc del Subministrament de Medicaments per al tractament de l'Esclerosi Múltiple
Contracte basat de l'Acord Marc del Subministrament de Medicaments per al tractament de l'Esclerosi Múltiple
https://contractaciopublica.gencat.cat/ecofin_pscp/AppJava/awardnotice.pscp?reqCode=viewDcan&idDoc=92209370&lawType=3
Source retrieved: 2026-10-12T05:43:07.947754Z